Bifogade filer
PDF
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Bio-Works Technologies AB announced today that its board of directors has approved an investment of 1 million SEK, enabling the company to double its production capacity within a year to meet the increasing demand for its purification products for the biopharmaceutical industry.
This capacity expansion is a strategic initiative aimed at ensuring the availability of high-quality products and shorter delivery times for the company's global customers.
"We are experiencing strong growth in demand for our products and are taking steps to ensure we can support our customers' needs for efficient purification solutions. By eliminating bottlenecks, we are doubling our capacity and creating a more robust and flexible supply chain that benefits our customers and strengthens our market position," says Lone Carlbom, CEO of Bio-Works.
The increased capacity will enable faster deliveries and improved access to Bio-Works' product portfolio, including WorkBeads™ resins, which are used in biopharmaceutical production and research worldwide. This investment aligns with Bio-Works' growth strategy and its goal of becoming a leading player in purification technologies for the life science industry.